3D Systems Narrows Losses as Healthcare Revenue Surges 21%
Event summary
- Q1 2026 revenue grew 1% YoY to $95.5M, or 11% excluding divestitures, driven by 21% growth in Healthcare Solutions.
- GAAP EPS loss narrowed to $(0.03) from $(0.28) YoY, with Adjusted EBITDA turning positive at $2.1M.
- Healthcare revenue surpassed Industrial revenue for the first time, growing 21% to $50.1M.
- Industrial revenue declined 15% YoY to $45.4M, though adjusted for divestitures, it grew 2% YoY.
- Company expects Q2 2026 revenue between $93M–$95M, with Adjusted EBITDA ranging from $(4)M to $(2)M.
The big picture
3D Systems is emerging from a multi-year downturn with a strategic pivot toward Healthcare, where it now rivals its Industrial segment in scale. The company's ability to maintain profitability improvements hinges on disciplined cost management and continued adoption of 3D printing in key markets like Dental, Med Tech, and Aerospace. The broader industry's recovery from economic risks will determine how quickly 3D Systems can capitalize on expanding global manufacturing capacity.
What we're watching
- Market Segmentation
- Whether 3D Systems can sustain its Healthcare growth momentum while stabilizing Industrial revenue.
- Cost Management
- The pace at which cost reduction initiatives will offset economic uncertainties.
- Product Innovation
- How new product launches in Dental and Aerospace will impact long-term revenue growth.
Related topics